These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 32850886)

  • 1. Predictors and Mortality of Rapidly Progressive Interstitial Lung Disease in Patients With Idiopathic Inflammatory Myopathy: A Series of 474 Patients.
    Li Y; Gao X; Li Y; Jia X; Zhang X; Xu Y; Gan Y; Li S; Chen R; He J; Sun X
    Front Med (Lausanne); 2020; 7():363. PubMed ID: 32850886
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiple values of
    Li Y; Zhou Y; Wang Q
    Clin Rheumatol; 2017 Oct; 36(10):2297-2305. PubMed ID: 28831580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myositis-specific autoantibodies and their clinical associations in idiopathic inflammatory myopathies: results from a cohort from China.
    Wen L; Chen X; Cheng Q; Nie L; Xu J; Yan T; Zhang X; Yang H; Sun W; Liu L; Xue J; Du Y
    Clin Rheumatol; 2022 Nov; 41(11):3419-3427. PubMed ID: 35859245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Tolerability of Nintedanib in Idiopathic-Inflammatory-Myopathy-Related Interstitial Lung Disease: A Pilot Study.
    Liang J; Cao H; Yang Y; Ke Y; Yu Y; Sun C; Yue L; Lin J
    Front Med (Lausanne); 2021; 8():626953. PubMed ID: 33614683
    [No Abstract]   [Full Text] [Related]  

  • 5. The lungs were on fire: a pilot study of
    Liang J; Cao H; Liu Y; Ye B; Sun Y; Ke Y; He Y; Xu B; Lin J
    Arthritis Res Ther; 2021 Jul; 23(1):198. PubMed ID: 34301306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic inflammatory myopathies: CT characteristics of interstitial lung disease and their association(s) with myositis-specific autoantibodies.
    Laporte A; Mariampillai K; Allenbach Y; Pasi N; Donciu V; Toledano D; Granger B; Benveniste O; Grenier PA; Boussouar S
    Eur Radiol; 2022 May; 32(5):3480-3489. PubMed ID: 35022809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic role of C-reactive protein to albumin ratio and anti-MDA5 antibody-positive in idiopathic inflammatory myopathy: a retrospective study.
    Zhou P; Shen Q; Zhou S; Ouyang X; Guo T; Song M; Guo W; Zhang Y; Peng H
    Sci Rep; 2023 Mar; 13(1):3863. PubMed ID: 36890164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-FDG PET/CT and HRCT: a combined tool for risk stratification in idiopathic inflammatory myopathy-associated interstitial lung disease.
    Zhang Y; Chen Z; Long Y; Zhang B; He Q; Tang K; Zhang X
    Clin Rheumatol; 2022 Oct; 41(10):3095-3105. PubMed ID: 35759126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Observational Study on the Clinical Characteristics and Prognosis of Patients With Interstitial Lung Disease Secondary to Dermatomyositis and Antisynthetase Syndrome.
    Lei L; Ma Z; Ma X; Pan D; Chen Z; Qin F; Dong F
    Int J Rheumatol; 2024; 2024():9679944. PubMed ID: 39364301
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognosis of adult idiopathic inflammatory myopathy-associated interstitial lung disease: a retrospective study of 679 adult cases.
    Li S; Sun Y; Shao C; Huang H; Wang Q; Xu K; Zhang X; Liu P; Zeng X; Xu Z
    Rheumatology (Oxford); 2021 Mar; 60(3):1195-1204. PubMed ID: 32894294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of rapidly progressive interstitial lung disease and mortality in patients with autoantibodies against melanoma differentiation-associated protein 5 dermatomyositis.
    So J; So H; Wong VT; Ho R; Wu TY; Wong PC; Tam LH; Ho C; Lam TT; Chung YK; Li WL; To CH; Lau CS; Mok CC; Tam LS
    Rheumatology (Oxford); 2022 Nov; 61(11):4437-4444. PubMed ID: 35157042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum ferritin as a significant biomarker for patients with idiopathic inflammatory myopathy-associated interstitial lung disease: A systematic review and meta-analysis.
    He X; Ji J; Chen X; Luo Z; Fang S; Yan H; Guo L
    Semin Arthritis Rheum; 2024 Feb; 64():152350. PubMed ID: 38086199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Outcomes and Prognosis Factors in Patients With Idiopathic Inflammatory Myopathies Based on Myositis-Specific Autoantibodies: A Single Cohort Study.
    Jiang W; Shi J; Yang H; Tian X; Yang H; Chen Q; Zhang L; Peng Q; Wang G; Lu X
    Arthritis Care Res (Hoboken); 2023 May; 75(5):1175-1182. PubMed ID: 35921214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated spleen FDG uptake predicts unfavorable outcome in adult idiopathic-inflammatory-myopathy patients: a crisis beyond muscles.
    Liu Y; Wang G; Wang H; Zhao X; Chen D; Su X; Yan J; Liang J; Lin J; Zhao K
    Clin Rheumatol; 2022 Jul; 41(7):2103-2112. PubMed ID: 35305186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pleural effusion as a predictor of rapidly progressive interstitial lung disease and mortality in idiopathic inflammatory myopathies.
    Liang X; Ren H; Xiao F; Zheng S; Wang R; Huang C; Guo J; Li J; Zhu J
    Clin Exp Rheumatol; 2024 Jul; ():. PubMed ID: 39051167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Systematic Review and Metaanalysis of Predictors of Mortality in Idiopathic Inflammatory Myopathy-Associated Interstitial Lung Disease.
    Hannah JR; Law HE; Gordon T; Rooney M; Buazon A; Adas M; Nagra D; Stovin C; Galloway J; Gordon PA
    J Rheumatol; 2023 Mar; 50(3):373-383. PubMed ID: 36379584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and prognosis of idiopathic inflammatory myopathies with coexistent multiple myositis-specific antibodies.
    Liang X; Wu J; Ren H; Li M; Huang C; Guo JG; Li D; Li J; Zhu J
    Clin Exp Rheumatol; 2024 May; ():. PubMed ID: 38819961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of risk factors of interstitial lung disease and mortality rates in Chinese patients with idiopathic inflammatory myopathy.
    Bai Z; Shen G; Dong L
    Int J Rheum Dis; 2021 Jun; 24(6):815-827. PubMed ID: 34028988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seasonal Effect on Disease Onset and Presentation in Anti-MDA5 Positive Dermatomyositis.
    So H; So J; Lam TT; Wong VT; Ho R; Li WL; Lau CS; Tam LS
    Front Med (Lausanne); 2022; 9():837024. PubMed ID: 35187011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Clinical Risk Model to Predict Rapidly Progressive Interstitial Lung Disease Incidence in Dermatomyositis.
    Li Y; Li Y; Wang Y; Shi L; Lin F; Zhang Z; Zhang J; Liu Y; Liu X; Xu F; Sun X
    Front Med (Lausanne); 2021; 8():733599. PubMed ID: 34646845
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.